QIAGEN NV (QGEN)
34.89
-0.20
(-0.57%)
USD |
NYSE |
May 21, 16:00
34.91
+0.02
(+0.06%)
After-Hours: 19:59
QIAGEN Cash from Investing (Quarterly) : 211.47M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CDT Equity, Inc. | 0.595M |
| Thermo Fisher Scientific, Inc. | -8.961B |
| ICON plc | -59.31M |
| InflaRx NV | 7.182M |
| Adaptive Biotechnologies Corp. | 9.143M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 100.63M |
| Cash from Financing (Quarterly) | -503.66M |
| Free Cash Flow | 403.87M |
| Free Cash Flow Per Share (Quarterly) | 0.2496 |
| Free Cash Flow to Equity (Quarterly) | 217.96M |
| Free Cash Flow to Firm (Quarterly) | 60.91M |
| Free Cash Flow Yield | 5.57% |